Product LiabilityRSS

  • March 11, 2009

    Grand Jury Probes Stryker Over Device Marketing

    Federal grand jurors are investigating whether Stryker Corp. subsidiary Stryker Biotech illegally promoted its medical products and filed false reports with the U.S. Food and Drug Administration, the medical technology company revealed Tuesday.

  • March 10, 2009

    Medtronic Plaintiffs Can Revise Pleadings Post-Wyeth

    Following the U.S. Supreme Court’s tectonic ruling in Wyeth v. Levine, a federal judge has allowed plaintiffs in the multidistrict litigation over Medtronic Inc.'s Sprint Fidelis defibrillator leads to revise their proposed pleadings.

  • March 10, 2009

    Investor Class Approved In Suit V. Boston Scientific

    A judge certified a class of shareholders Tuesday in a long-standing consolidated securities fraud action against Boston Scientific Corp. and several of its executives alleging the biotech company failed to disclose information about the recall of one of its stents.

  • March 10, 2009

    Judge Tosses Medtronic Securities Class Action

    A judge has dismissed a securities class action against Medtronic Inc. that alleged the medical device giant covered up fatal defects in its defibrillators and was responsible for the company's stock price collapse in 2007.

  • March 10, 2009

    Maytag Issues Massive Recall Of Faulty Fridges

    Citing fire hazards, Maytag Corp. on Tuesday voluntarily recalled seven different brands of its refrigerators, encompassing 1.6 million appliances.

  • March 10, 2009

    Class Cert. Sought In Laptop Defect Suit V. Toshiba

    Plaintiffs filed a motion for class certification Monday in a suit accusing Toshiba America Information Systems Inc. of willfully concealing information about defective laptop hinges.

  • March 10, 2009

    Jury Clears Kia In Liability Suit Over Sorento SUV

    A jury has found Kia Motors America Inc. and Kia Motors Corp. not liable for $30 million in personal and punitive damages, in a case involving safety provisions in Kia's Sorento line of SUVs.

  • March 11, 2009

    Genzyme Warned Over Procedures At Drug Plant

    The U.S. Food and Drug Administration has threatened to withhold approval of Genzyme Corp.'s drug shipments and to delay approval of its drug Lumizyme, a treatment for Pompe disease, after inspections revealed “significant deviations” from manufacturing protocols at a Massachusetts plant.

  • March 9, 2009

    Preemption Motion Withdrawn In NuvaRing MDL

    Days after the U.S. Supreme Court's decision in Wyeth v. Levine, attorneys for Organon International Inc. in the multidistrict litigation over its NuvaRing contraceptive have withdrawn a motion that sought summary judgment on preemption grounds.

  • March 9, 2009

    Tort Firm Bids To Sanction AIG In Defamation Case

    Wendler & Ezra PC is urging a federal judge to impose sanctions on American International Group Inc. for failing to turn over documents that allegedly relate to the insurer's investigation of a defamatory online posting meant to deter the tort law firm's potential clients.

  • March 9, 2009

    FDA Reprimands Gilead Over Letairis Statements

    The U.S. Food and Drug Administration has chastised Gilead Sciences Inc. for a sales representative's “false and misleading” statements that misbranded the hypertension drug Letairis and minimized “serious risks” associated with the medication.

  • March 9, 2009

    LP Off Hook For Repair Costs Over Faulty Siding

    Finding that a 14-year-old class action settlement with building products maker Louisiana-Pacific Corp. precluded Lester Building Systems from having to repair faulty LP-made siding on customers' hog barns, the Supreme Court of Minnesota has ruled that LP does not have to pay an additional $11.2 million in repair-cost damages to Lester.

  • March 9, 2009

    High Court Remands Cases In Light Of Wyeth

    Just days after the U.S. Supreme Court ruled in the key product liability case Wyeth v. Levine, the high court vacated and remanded two cases that also center on the issue of preemption.

  • March 9, 2009

    Schering Merger Includes Legal Headaches For Merck

    As Merck & Co. prepares to join forces with Schering-Plough Co. in a $41.1 billion deal, the drugmaker stands ready to inherit a host of legal problems — including antitrust, employment, intellectual property and product liability suits — right along with an expanded arsenal of drugs and medical technology.

  • March 9, 2009

    High Court Seeks SG Input In Banking Privacy Suit

    The U.S. Supreme Court has asked the acting solicitor general to weigh in on a case over whether a California law that restricts sharing of customer information among financial institutions is preempted by the federal Fair Credit Reporting Act.

  • March 9, 2009

    Medtronic MDL Judge Refuses Recusal

    The federal judge overseeing multidistrict litigation involving Medtronic Inc.’s Sprint Fidelis defibrillator leads has refused to recuse himself from the proceedings despite allegations by the plaintiffs’ attorneys that he failed to disclose that his son works for a law firm with Medtronic connections.

  • March 10, 2009

    MarkWest Pipeline Fixes Not Insured: 10th Circ.

    Finding that several insurers were correct in denying coverage for remedial actions following a gas pipeline explosion, the U.S. Court of Appeals for the Tenth Circuit has affirmed a ruling against natural gas transmission company MarkWest Energy Partners LP, which had sued Liberty Mutual Insurance Co., Ace American Insurance Co. and others for alleged breach of contract and bad faith.

  • March 6, 2009

    Continental To Pay Up To $8M To Settle Tire Actions

    Two class actions accusing Continental Tire North America Inc. of selling tires it knew would wear prematurely came to a close Thursday as a federal judge approved a final settlement between the parties.

  • March 6, 2009

    House Committee Gives FDA OK To Regulate Tobacco

    The U.S. House of Representatives Energy and Commerce Committee has approved a measure that would place tobacco under the purview of the U.S. Food and Drug Administration.

  • March 6, 2009

    Bill Aims To Give FDA Power To Recall Tainted Food

    In response to a series of foodborne illness scares, two U.S. lawmakers have unveiled a bill that would for the first time give the U.S. Food and Drug Administration the authority to recall contaminated food.